ArticlePolymers2022
Influence of the Carbon and Nitrogen Sources on Diabolican Production by the Marine
Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 14 citations in OpenAlex.
- Improvement of water retention capacity in sandy soil with the application of a crude exopolysaccharide-containing fermentation broth produced by Kocuria carniphila AUMC B-453.World journal of microbiology & biotechnology · 2025Article
- Enhanced production and structural characterization of exopolysaccharide from Sporocarcina psychrophile MTCC 2908 through two step optimization for therapeutic evaluation.Scientific reports · 2025Article
- Exploring the Exopolysaccharide Production Potential of Bacterial Strains Isolated from Tunisian Blue CrabMolecules (Basel, Switzerland) · 2024Article
- Marine versus Non-Marine Bacterial Exopolysaccharides and Their Skincare Applications.Marine drugs · 2023Review
- NMR Analyses of the Enzymatic Degradation End-Products of Diabolican: The Secreted EPS ofMarine drugs · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent advances in glycobiotechnology show that bacterial exopolysaccharides (EPS) presenting glycosaminoglycan (GAG)-like properties can provide a valuable source of bio-active macromolecules for industrial applications. The HE800 EPS, named diabolican, is a marine-derived anionic high-molecular-weight polysaccharide produced by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.